154 related articles for article (PubMed ID: 21177754)
1. Highly reactive anti-myelin oligodendrocyte glycoprotein antibodies differentiate demyelinating diseases from viral encephalitis in children.
Lalive PH; Häusler MG; Maurey H; Mikaeloff Y; Tardieu M; Wiendl H; Schroeter M; Hartung HP; Kieseier BC; Menge T
Mult Scler; 2011 Mar; 17(3):297-302. PubMed ID: 21177754
[TBL] [Abstract][Full Text] [Related]
2. Antibodies to MOG are transient in childhood acute disseminated encephalomyelitis.
Pröbstel AK; Dornmair K; Bittner R; Sperl P; Jenne D; Magalhaes S; Villalobos A; Breithaupt C; Weissert R; Jacob U; Krumbholz M; Kuempfel T; Blaschek A; Stark W; Gärtner J; Pohl D; Rostasy K; Weber F; Forne I; Khademi M; Olsson T; Brilot F; Tantsis E; Dale RC; Wekerle H; Hohlfeld R; Banwell B; Bar-Or A; Meinl E; Derfuss T
Neurology; 2011 Aug; 77(6):580-8. PubMed ID: 21795651
[TBL] [Abstract][Full Text] [Related]
3. [Myelin oligodendrocyte glycoprotein (MOG) antibody and demyelination].
Fukaura H
Nihon Rinsho; 2010 Jun; 68 Suppl 6():637-40. PubMed ID: 20942151
[No Abstract] [Full Text] [Related]
4. Temporal dynamics of anti-MOG antibodies in CNS demyelinating diseases.
Di Pauli F; Mader S; Rostasy K; Schanda K; Bajer-Kornek B; Ehling R; Deisenhammer F; Reindl M; Berger T
Clin Immunol; 2011 Mar; 138(3):247-54. PubMed ID: 21169067
[TBL] [Abstract][Full Text] [Related]
5. Autoantibodies recognizing native MOG are closely associated with active demyelination but not with neuroinflammation in chronic EAE.
Ohtani S; Kohyama K; Matsumoto Y
Neuropathology; 2011 Apr; 31(2):101-11. PubMed ID: 20573031
[TBL] [Abstract][Full Text] [Related]
6. Antibodies to native myelin oligodendrocyte glycoprotein in children with inflammatory demyelinating central nervous system disease.
Brilot F; Dale RC; Selter RC; Grummel V; Kalluri SR; Aslam M; Busch V; Zhou D; Cepok S; Hemmer B
Ann Neurol; 2009 Dec; 66(6):833-42. PubMed ID: 20033986
[TBL] [Abstract][Full Text] [Related]
7. Anti-myelin antibodies modulate clinical expression of childhood multiple sclerosis.
O'Connor KC; Lopez-Amaya C; Gagne D; Lovato L; Moore-Odom NH; Kennedy J; Krupp L; Tenembaum S; Ness J; Belman A; Boyko A; Bykova O; Mah JK; Stoian CA; Waubant E; Kremenchutzky M; Ruggieri M; Bardini MR; Rensel M; Hahn J; Weinstock-Guttman B; Yeh EA; Farrell K; Freedman MS; Iivanainen M; Bhan V; Dilenge M; Hancock MA; Gano D; Fattahie R; Kopel L; Fournier AE; Moscarello M; Banwell B; Bar-Or A
J Neuroimmunol; 2010 Jun; 223(1-2):92-9. PubMed ID: 20381173
[TBL] [Abstract][Full Text] [Related]
8. Anti-myelin antibodies predict the clinical outcome after a first episode suggestive of MS.
Tomassini V; De Giglio L; Reindl M; Russo P; Pestalozza I; Pantano P; Berger T; Pozzilli C
Mult Scler; 2007 Nov; 13(9):1086-94. PubMed ID: 17468447
[TBL] [Abstract][Full Text] [Related]
9. Increased interleukin-6 correlates with myelin oligodendrocyte glycoprotein antibodies in pediatric monophasic demyelinating diseases and multiple sclerosis.
Horellou P; Wang M; Keo V; Chrétien P; Serguera C; Waters P; Deiva K
J Neuroimmunol; 2015 Dec; 289():1-7. PubMed ID: 26616865
[TBL] [Abstract][Full Text] [Related]
10. Myelin oligodendrocyte glycoprotein antibodies in pathologically proven multiple sclerosis: frequency, stability and clinicopathologic correlations.
Pittock SJ; Reindl M; Achenbach S; Berger T; Bruck W; Konig F; Morales Y; Lassmann H; Bryant S; Moore SB; Keegan BM; Lucchinetti CF
Mult Scler; 2007 Jan; 13(1):7-16. PubMed ID: 17294606
[TBL] [Abstract][Full Text] [Related]
11. Antibody responses to EBV and native MOG in pediatric inflammatory demyelinating CNS diseases.
Selter RC; Brilot F; Grummel V; Kraus V; Cepok S; Dale RC; Hemmer B
Neurology; 2010 May; 74(21):1711-5. PubMed ID: 20410464
[TBL] [Abstract][Full Text] [Related]
12. Frontline: Epitope recognition on the myelin/oligodendrocyte glycoprotein differentially influences disease phenotype and antibody effector functions in autoimmune demyelination.
von Büdingen HC; Hauser SL; Ouallet JC; Tanuma N; Menge T; Genain CP
Eur J Immunol; 2004 Aug; 34(8):2072-83. PubMed ID: 15259004
[TBL] [Abstract][Full Text] [Related]
13. Myelin oligodendrocyte glycoprotein antibodies and multiple sclerosis in healthy young adults.
Wang H; Munger KL; Reindl M; O'Reilly EJ; Levin LI; Berger T; Ascherio A
Neurology; 2008 Oct; 71(15):1142-6. PubMed ID: 18753473
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic modalities in multiple sclerosis: perspectives in children.
Chou IJ; Whitehouse WP; Wang HS; Tanasescu R; Constantinescu CS
Biomed J; 2014; 37(2):50-9. PubMed ID: 24732659
[TBL] [Abstract][Full Text] [Related]
15. [Anti-MOG immunoglobulin IgM].
Fukaura H; Kikuchi S
Nihon Rinsho; 2005 Jul; 63 Suppl 7():593-5. PubMed ID: 16111341
[No Abstract] [Full Text] [Related]
16. Clinical features and long-term outcome of a group of Japanese children with inflammatory central nervous system disorders and seropositivity to myelin-oligodendrocyte glycoprotein antibodies.
Hino-Fukuyo N; Haginoya K; Nakashima I; Sato DK; Takahashi T; Misu T; Fujihara K; Hirose M; Kakisaka Y; Uematsu M; Kobayashi T; Kure S
Brain Dev; 2015 Oct; 37(9):849-52. PubMed ID: 25748628
[TBL] [Abstract][Full Text] [Related]
17. Preparation of highly purified human myelin oligodendrocyte glycoprotein in quantities sufficient for encephalitogenicity and immunogenicity studies.
Abo S; Bernard CC; Webb M; Johns TG; Alafaci A; Ward LD; Simpson RJ; Kerlero de Rosbo N
Biochem Mol Biol Int; 1993 Aug; 30(5):945-58. PubMed ID: 8220243
[TBL] [Abstract][Full Text] [Related]
18. Anti-MOG antibodies plead against MS diagnosis in an Acquired Demyelinating Syndromes cohort.
Ketelslegers IA; Van Pelt DE; Bryde S; Neuteboom RF; Catsman-Berrevoets CE; Hamann D; Hintzen RQ
Mult Scler; 2015 Oct; 21(12):1513-20. PubMed ID: 25662345
[TBL] [Abstract][Full Text] [Related]
19. B Cell, Th17, and Neutrophil Related Cerebrospinal Fluid Cytokine/Chemokines Are Elevated in MOG Antibody Associated Demyelination.
Kothur K; Wienholt L; Tantsis EM; Earl J; Bandodkar S; Prelog K; Tea F; Ramanathan S; Brilot F; Dale RC
PLoS One; 2016; 11(2):e0149411. PubMed ID: 26919719
[TBL] [Abstract][Full Text] [Related]
20. Severe post-EBV encephalopathy associated with myelin oligodendrocyte glycoprotein-specific immune response.
Jilek S; Kuhle J; Meylan P; Reichhart MD; Pantaleo G; Du Pasquier RA
J Neuroimmunol; 2007 Dec; 192(1-2):192-7. PubMed ID: 17980440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
